Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097614 · ClinicalTrials.gov registry record · NA
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
A NA study, sponsored by Oculeve.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03097614 is a NA study that has completed, run by Oculeve. The registered enrollment target is 57 participants.
The verdict
NCT03097614, a NA study, has completed, sponsored by Oculeve.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study characterizes acute dry eye symptom control, assessed during exposure to a Controlled Adverse Environment, following use of the TrueTear for 45 days.
Interventions
- DEVICE TrueTear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03097614
The ClinicalTrials.gov registry entry for NCT03097614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oculeve, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TrueTear is the first listed.
NCT03097614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03097614 about?
NCT03097614 is a clinical study titled "Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment". This study characterizes acute dry eye symptom control, assessed during exposure to a Controlled Adverse Environment, following use of the TrueTear for 45 days.
What is the current status of trial NCT03097614?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-03-31. Estimated completion is 2017-06-26.
What interventions are being tested in trial NCT03097614?
The interventions under investigation include: TrueTear (DEVICE).
Who is sponsoring clinical trial NCT03097614?
This trial is sponsored by Oculeve, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.